Updated: May 13, 2025

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Hui Lu1, Xiaoyan Zhao2, Liqiong Liu3
1Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Natural killer (NK) cell numbers and function are reduced in diffuse large B-cell lymphoma (DLBCL). Blocking T-cell immunoreceptor with Ig and ITIM domains (TIGIT) restores NK cell antitumor activity, suggesting TIGIT as a therapeutic target for DLBCL.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: